1. A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors. (December 2021) Authors: Martorana, F.; Colombo, I.; Treglia, G.; Gillessen, S.; Stathis, A. Journal: Cancer treatment reviews Issue: Volume 101(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer. (March 2021) Authors: Chiappa, M.; Guffanti, F.; Bertoni, F.; Colombo, I.; Damia, G. Journal: Drug resistance updates Issue: Volume 55(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of short‐to‐long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). (4th July 2017) Authors: Ripolone, M.; Violano, R.; Ronchi, D.; Mondello, S.; Nascimbeni, A.; Colombo, I.; Fagiolari, G.; Bordoni, A.; Fortunato, F.; Lucchini, V.; Saredi, S.; Filosto, M.; Musumeci, O.; Tonin, P.; Mongini, T.; Previtali, S.; Morandi, L.; Angelini, C.; Mora, M.; Sandri, M. Journal: Neuropathology & applied neurobiology Issue: Volume 44:Number 5(2018) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗